Changes to federal student loan policy reintroduce borrowing caps for graduate and professional education, impacting how future physicians finance medical training.
Novo Nordisk’s once-daily GLP-1 tablet reduced major adverse cardiovascular events in high-risk adults, including those without prior heart attack or stroke.